AUROGEN INC has a total of 11 patent applications. Its first patent ever was published in 1996. It filed its patents most often in EPO (European Patent Office), Australia and Canada. Its main competitors in its focus markets pharmaceuticals are METABOLIC SOLUTIONS DEV COMPAN, DIAMYD THERAPEUTICS AB and AQUMEN BIOPHARMACEUTICALS K K.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 3 | |
#2 | Australia | 2 | |
#3 | Canada | 2 | |
#4 | China | 1 | |
#5 | Japan | 1 | |
#6 | Republic of Korea | 1 | |
#7 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Ishii Douglas N | 7 |
#2 | Ishi Douglas N | 3 |
Publication | Filing date | Title |
---|---|---|
EP1948222A1 | Method for treating disease or disorder of adult central nervous system associated with tissue shrinkage or atrophy by administration of insulin | |
AU2001288443B2 | Method for treating the central nervous system by administration of IGF structural analogs |